Publication | Closed Access

A hematological remission by clonal hematopoiesis after treatment with recombinant human granulocyte-macrophage colony-stimulating factor and erythropoietin in a patient with therapy-related myelodysplastic syndrome

Bone Marrow FailureImmunologyHematologyPathologyMyeloid NeoplasiaMyelopoiesisTherapy-related Myelodysplastic SyndromeImmunotherapyMedicineClonal HematopoiesisAplastic AnemiaHematological Remission